19.96
price down icon1.67%   -0.34
after-market 시간 외 거래: 20.35 0.39 +1.95%
loading

Denali Therapeutics Inc (DNLI) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - 14.54
Operating Expenses
7.29%
134.96
145.58 123.19 116.59 132.25
Operating Income/Loss
7.29%
-134.96
-145.58 -123.19 -116.59 -117.72
Income/Loss From Continuing Operations Before Tax
6.66%
-124.12
-132.97 -107.19 -99.03 -101.80
Income/Loss From Continuing Operations After Tax
6.66%
-124.12
-132.97 -107.19 -99.03 -101.80
Net Income/Loss
6.66%
-124.12
-132.97 -107.19 -99.03 -101.80
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.13%
171.45
171.22 169.46 168.83 149.40
Diluted Average Shares
0.13%
171.45
171.22 169.46 168.83 149.40
Basic Earnings Per Share
7.69%
-0.72
-0.78 -0.63 -0.59 -0.68
Diluted Earnings Per Share
7.69%
-0.72
-0.78 -0.63 -0.59 -0.68
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$39.73
price up icon 1.44%
$31.74
price down icon 0.91%
$102.52
price up icon 2.03%
$96.25
price up icon 0.27%
biotechnology ONC
$322.63
price down icon 2.61%
$204.00
price down icon 0.51%
자본화:     |  볼륨(24시간):